A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2002
10/16/2002	EP1248795A1 Antisense modulation of macrophage migration inhibitory factor expression
10/16/2002	EP1248787A2 Novel subtituted pyrazolo[4, 3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
10/16/2002	EP1248786A1 Benzofuran derivatives
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248781A1 Pyrazole cyclic amp-specific pde inhibitors
10/16/2002	EP1248779A2 Glycosidase ihhibitors and preparation thereof
10/16/2002	EP1248770A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
10/16/2002	EP1248647A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
10/16/2002	EP1248643A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
10/16/2002	EP1248635A1 Antisense modulation of glycogen synthase kinase 3 alpha expression
10/16/2002	EP1248633A1 Antisense modulation of glycogen synthase kinase 3 beta expression
10/16/2002	EP1248632A2 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain
10/16/2002	EP1248622A1 Anxiety method
10/16/2002	EP1248621A1 Method and composition for the treatment of pain
10/16/2002	EP1248619A1 Amorphous paroxetine compositon
10/16/2002	EP1248617A1 2-aza-bicyclo 2.2.2]octane nmda/nr2b antagonists
10/16/2002	EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002	EP1248613A1 Clonidine preparations
10/16/2002	EP1248609A1 Method of treating benign forgetfulness
10/16/2002	EP1248607A1 Urotensin-ii receptor antagonists
10/16/2002	EP1248606A1 Use of fumaric acid derivatives for treating mitochondrial diseases
10/16/2002	EP1248605A2 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
10/16/2002	EP1248595A1 Multi-step drug dosage forms
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP1248517A2 Clonal propagation of primate offspring by embryo splitting
10/16/2002	EP1140065A4 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/16/2002	EP0973794B1 Netrin receptors
10/16/2002	EP0941108B1 Wound healing and treatment of fibrosis
10/16/2002	EP0932400B1 Anticonvulsant derivatives useful in treating neuropathic pain
10/16/2002	EP0891365B1 Benzoxazines for enhancing synaptic responses
10/16/2002	EP0721343B1 Pharmaceutical formulations of nerve growth factor
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	EP0528978B1 Mikrocaspules for controlled release and their use to stimulate nerve fiber growth
10/16/2002	CN1374967A Compounds for the treatment of ischemia
10/16/2002	CN1374966A 嘌呤衍生物 Purine derivatives
10/16/2002	CN1374961A Azepinoindole derivatives, the production and use thereof
10/16/2002	CN1374956A 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof and their use as anticonvulsants
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374949A 毒蕈碱拮抗剂 Muscarinic antagonist
10/16/2002	CN1374948A 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same
10/16/2002	CN1374867A Quetiapine granules
10/16/2002	CN1374866A Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/16/2002	CN1374859A 药物粉剂 Drug powder
10/16/2002	CN1374127A Analgesic and its prepn
10/16/2002	CN1374120A Pseudozoogloea adjuvant and its prepn and application
10/16/2002	CN1374117A Chinese medicine for treating intractable headache and dizziness and its prepn process
10/16/2002	CN1374101A Kidney benefiting belt
10/16/2002	CN1092658C Mesylate trihydrate salt of 5-(2-(4-(1,2-benziisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2-(1H)-indol-2-one
10/16/2002	CN1092657C One pot synthesis of 2-oxazolidinone derivatives
10/16/2002	CN1092655C 哌啶衍生物 Piperidine derivatives
10/16/2002	CN1092653C (4-piperidnyl)-1H-2-benzopyran derivatives used as antipsychotic agent
10/16/2002	CN1092652C 2-imidazolinylaminoindole compound and composition containing the same use
10/16/2002	CN1092643C Certain aminomethyl phenylidazole derivatives, for intensifying memory
10/16/2002	CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002	CA2406198A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
10/16/2002	CA2406161A1 2-guanidino-4-arylquinazolines as nhe-3 inhibitors
10/15/2002	US6465715 Dna fragments from the promoter region of the c. elegans ul6 gene which are capable of functioning as promoters directing gene expression in the excretory cell of c. elegans are provided and also expression vectors and transgenic c. elegans
10/15/2002	US6465687 Thyroid receptor ligands and method
10/15/2002	US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002	US6465660 Isoindoloindolone compounds
10/15/2002	US6465524 Therapy for obesity; psychological disorders
10/15/2002	US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002	US6465517 Taurine, coenzyme q10 and additionally creatine, l-carnitine, certain vitamins and minerals, carbohydrates, proteins, fats and herbal extracts
10/15/2002	US6465511 Treatment of septic shock
10/15/2002	US6465507 Antitumor agents
10/15/2002	US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002	US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465489 Such as 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-(4-(n',n'-dimethylureido)-4 -phenylpiperidin-1-)propyl)piperidine; psychiatric and psychosomatic illnesses, hypertension, central or peripheral pathology
10/15/2002	US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002	US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002	US6465479 Pyridomorphinans and use thereof
10/15/2002	US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002	US6465472 Substituted quinazolines and analogs and use thereof
10/15/2002	US6465470 R-hydroxynefazodone
10/15/2002	US6465469 Depression, migraine headaches, panic disorders, post traumatic stress disorder and sleep disorders; side effect reduction
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002	US6465462 Cognition enhancement for dementing illnesses such as alzheimer's disease
10/15/2002	US6465461 5-amino-6-(2,3,5-trichlorophenyl)-1,2,4-triazine; potent, selective anticonvulsant; dihydrofolate reductase inhibitor; analgesics; epilepsy, bipolar disorder, pain
10/15/2002	US6465458 Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
10/15/2002	US6465453 Azepine derivatives having effects on serotonin related systems
10/15/2002	US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/15/2002	US6465248 Methods for producing and preparing cells for cell therapy
10/15/2002	US6465231 GSK3 polypeptides
10/15/2002	US6465003 Drug delivery
10/15/2002	US6464986 Method for treating pain by peripheral administration of a neurotoxin
10/15/2002	CA2310926C A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
10/15/2002	CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
10/15/2002	CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/15/2002	CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/10/2002	WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002	WO2002079471A2 Cholinesterase-anchoring protein, corresponding nucleic acids and their use for preparing medicines
10/10/2002	WO2002079458A1 Central nerve system precursor cells inducing synaptogenic neurons in spinal cord
10/10/2002	WO2002079456A2 A method for the preparation of immunologically inert amniotic membranes
10/10/2002	WO2002079448A2 G-protein coupled receptors
10/10/2002	WO2002079441A2 Secreted proteins
10/10/2002	WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002	WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002	WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002	WO2002079236A1 Alpha conotoxin peptides with analgesic properties

1 ... 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 ... 1833